Century Therapeutics, Inc.

Historical 13F Holders

Symbol
IPSC
CUSIP
15673T100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 15673T100 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13G
9.9% 1/16/2026
Event 1/9/2026
TCG Crossover GP II, LLC 13G
9.9% 1/15/2026
Event 1/9/2026
Deep Track Capital, LP 13G
7.3% 1/15/2026
Event 1/8/2026
Commodore Capital LP 13G
7.1% 1/16/2026
Event 1/9/2026
RTW Investments, LP 13G
7.1% 5/15/2026
Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P. 13G
7.1% 1/16/2026
Event 1/9/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Bain Capital Life Sciences Opportunities III, LP 13G/A 4.1% 11/14/2025
Event 9/30/2025
Casdin Capital, LLC 13G/A
3.7% 5/15/2025
Event 3/31/2025
Point72 Asset Management, L.P. 13G/A
3.3% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 103 163 M $277M
2026 Q2 102 158 M $387M
2026 Q1 75 139 M $312M
2025 Q4 47 25.7 M $25.6M
2025 Q3 57 20.3 M $10.1M
2025 Q2 66 22.6 M $12.6M
2025 Q1 71 29.6 M $14.1M
2024 Q4 73 36.4 M $36.8M
2024 Q3 68 39.6 M $67.8M
2024 Q2 62 40.1 M $102M
2024 Q1 68 23.1 M $96.6M
2023 Q4 64 17.7 M $58.7M
2023 Q3 56 18.1 M $36.1M
2023 Q2 65 19.3 M $61.0M
2023 Q1 65 20.0 M $69.5M
2022 Q4 67 20.9 M $107M
2022 Q3 57 21.1 M $209M
2022 Q2 57 21.8 M $183M
2022 Q1 53 22.2 M $279M
2021 Q4 51 21.1 M $335M
2021 Q3 50 19.8 M $496M
2021 Q2 37 16.9 M $491M